Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290)
South Korea
· Delayed Price · Currency is KRW 8,890.00
+60.00 (0.68%)
Mar 10, 2026, 9:20 AM KST
Kwang Dong Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 323,704 | 218,039 | 297,799 | 244,840 | 305,229 | 421,076 | Upgrade
|
| Market Cap Growth | 52.33% | -26.78% | 21.63% | -19.79% | -27.51% | 59.98% | Upgrade
|
| Enterprise Value | 437,071 | 335,136 | 283,794 | 196,173 | 300,829 | 390,078 | Upgrade
|
| Last Close Price | 8830.00 | 5340.00 | 7293.42 | 5771.70 | 7077.30 | 9633.43 | Upgrade
|
| PE Ratio | 11.93 | 5.39 | 8.06 | 10.13 | 12.71 | 9.28 | Upgrade
|
| Forward PE | - | 14.32 | 14.32 | 14.32 | 14.32 | 14.32 | Upgrade
|
| PS Ratio | 0.20 | 0.13 | 0.20 | 0.17 | 0.23 | 0.34 | Upgrade
|
| PB Ratio | 0.51 | 0.35 | 0.51 | 0.45 | 0.58 | 0.84 | Upgrade
|
| P/TBV Ratio | 0.58 | 0.40 | 0.59 | 0.49 | 0.63 | 0.91 | Upgrade
|
| P/FCF Ratio | 47.16 | - | - | 6.54 | 9.80 | 23.97 | Upgrade
|
| P/OCF Ratio | 5.63 | - | - | 3.90 | 5.56 | 18.45 | Upgrade
|
| EV/Sales Ratio | 0.27 | 0.20 | 0.19 | 0.14 | 0.23 | 0.31 | Upgrade
|
| EV/EBITDA Ratio | 11.41 | 7.51 | 5.16 | 3.75 | 5.10 | 5.88 | Upgrade
|
| EV/EBIT Ratio | 20.75 | 11.14 | 6.75 | 5.13 | 6.70 | 8.37 | Upgrade
|
| EV/FCF Ratio | 63.68 | - | - | 5.24 | 9.66 | 22.21 | Upgrade
|
| Debt / Equity Ratio | 0.46 | 0.46 | 0.40 | 0.25 | 0.25 | 0.22 | Upgrade
|
| Debt / EBITDA Ratio | 6.76 | 6.41 | 4.29 | 2.64 | 2.24 | 1.65 | Upgrade
|
| Debt / FCF Ratio | 41.98 | - | - | 3.69 | 4.24 | 6.25 | Upgrade
|
| Net Debt / Equity Ratio | 0.12 | 0.20 | 0.05 | -0.13 | -0.11 | -0.08 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.73 | 2.70 | 0.54 | -1.35 | -0.94 | -0.60 | Upgrade
|
| Net Debt / FCF Ratio | 10.74 | -1.37 | -0.63 | -1.89 | -1.79 | -2.25 | Upgrade
|
| Asset Turnover | 1.36 | 1.46 | 1.51 | 1.58 | 1.56 | 1.53 | Upgrade
|
| Inventory Turnover | 6.59 | 6.62 | 6.95 | 7.34 | 6.58 | 6.21 | Upgrade
|
| Quick Ratio | 1.02 | 0.95 | 1.03 | 1.23 | 1.32 | 1.24 | Upgrade
|
| Current Ratio | 1.41 | 1.55 | 1.46 | 1.71 | 1.81 | 1.93 | Upgrade
|
| Return on Equity (ROE) | 4.87% | 6.94% | 6.94% | 4.97% | 4.96% | 9.60% | Upgrade
|
| Return on Assets (ROA) | 1.32% | 1.67% | 2.62% | 2.63% | 3.28% | 3.59% | Upgrade
|
| Return on Invested Capital (ROIC) | 2.68% | 3.24% | 6.18% | 5.94% | 7.16% | 7.42% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.50% | 4.20% | 6.80% | 6.60% | 8.00% | 8.80% | Upgrade
|
| Earnings Yield | 9.02% | 18.57% | 12.41% | 9.87% | 7.87% | 10.78% | Upgrade
|
| FCF Yield | 2.12% | -40.31% | -15.62% | 15.29% | 10.20% | 4.17% | Upgrade
|
| Dividend Yield | 1.27% | - | - | 1.73% | 1.41% | 1.04% | Upgrade
|
| Payout Ratio | 13.46% | 9.90% | 11.11% | 16.99% | 17.10% | 6.98% | Upgrade
|
| Buyback Yield / Dilution | 1.64% | 1.10% | 1.48% | 0.11% | -1.48% | -2.24% | Upgrade
|
| Total Shareholder Return | 2.91% | 1.10% | 1.48% | 1.85% | -0.07% | -1.21% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.